APOLLO BioWellness Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
APOLLO BioWellness Incの収益はセグメントまたは地域別にどのように分けられていますか?
APOLLO BioWellness Inc の最大収益セグメントは Regenerative Medicine で、最新の利益発表における収益は 1,896,215 です。地域別に見ると、United States が APOLLO BioWellness Inc の主要市場であり、収益は 1,896,215 です。
APOLLO BioWellness Incは収益を上げていますか?
いいえ、最新の財務諸表によると、APOLLO BioWellness Incの純損失は$0です。
APOLLO BioWellness Incに負債はありますか?
いいえ、APOLLO BioWellness Incの負債は0です。
APOLLO BioWellness Incの発行済株式数は何株ですか?
APOLLO BioWellness Incの総発行済株式数は0株です。
主要データ
前終値
$0.0013
始値
$0.0012
当日レンジ
$0.0011 - $0.0013
52週レンジ
$0.0007 - $0.0235
取引高
--
平均取引高
3.3M
配当利回り
--
1株当たり利益(TTM)
-0.02
時価総額
$332.8K
KOANとは何ですか?
Resonate Blends, Inc. is a cannabis holding company, which engages in the provision of cannabis-based products. The company is headquartered in Calabasas, California. The firm is engaged in the field of regenerative medicine using biologic-based products. Its products are intended to market under third-party label exemptions. The firm is focused on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. The company is licensed under a patent-pending application to market a dual-acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Its products are being developed for consumer and professional markets.